NZX50 slides to nine-month low

NZX50 slides to nine-month low
A new drug has weighed on Fisher and Paykel's shares. (Image: Getty)
Graham Skellern
A weight-reducing drug is causing trouble for Fisher and Paykel Healthcare as the New Zealand sharemarket chalked up its sixth successive fall.The S&P/NZX 50 Index was on a downward slide all day and closed at 11,344.11, down 82.73 points or 0.72% – its lowest level for nine months.The index has now fallen 1.8% for the year and was at 11308.31 points on November 28.There were 42 gainers and 84 decliners on the main board, with 28.19 million shares worth $102.5m changing hands.Under pressureMarket heavyweight Fisher and Paykel Healthca...

More Markets

New open-banking regulations confirm phased Dec 1 start
Finance

New open-banking regulations confirm phased Dec 1 start

Open-banking regulations confirm Dec 1 start for biggest banks, prohibit fees and levies.

John Nichol appointed chair of PGG Wrightson
Primary Sector

John Nichol appointed chair of PGG Wrightson

Agria has shed some light on why it voted the way it did.

PGG Wrightson board shake-up stuns small shareholders
Primary Sector

PGG Wrightson board shake-up stuns small shareholders

Agria and Elders' endgame unclear after director oustings.